TW200407323A - Compounds against helicobacter activity - Google Patents

Compounds against helicobacter activity Download PDF

Info

Publication number
TW200407323A
TW200407323A TW092113000A TW92113000A TW200407323A TW 200407323 A TW200407323 A TW 200407323A TW 092113000 A TW092113000 A TW 092113000A TW 92113000 A TW92113000 A TW 92113000A TW 200407323 A TW200407323 A TW 200407323A
Authority
TW
Taiwan
Prior art keywords
substituted
group
compound
pharmaceutically acceptable
alkyl
Prior art date
Application number
TW092113000A
Other languages
English (en)
Chinese (zh)
Inventor
Giichi Sugimori
Moriyasu Masui
Kuniyoshi Nishida
Yasushi Hasegawa
Naotake Kobayashi
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of TW200407323A publication Critical patent/TW200407323A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW092113000A 2002-05-13 2003-05-13 Compounds against helicobacter activity TW200407323A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002137845 2002-05-13

Publications (1)

Publication Number Publication Date
TW200407323A true TW200407323A (en) 2004-05-16

Family

ID=29416824

Family Applications (1)

Application Number Title Priority Date Filing Date
TW092113000A TW200407323A (en) 2002-05-13 2003-05-13 Compounds against helicobacter activity

Country Status (3)

Country Link
AU (1) AU2003235908A1 (fr)
TW (1) TW200407323A (fr)
WO (1) WO2003095453A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100561357B1 (ko) * 2003-11-21 2006-03-16 삼성전자주식회사 나프탈렌테트라카르복시디이미드 유도체 및 이를 이용한전자사진 감광체
WO2015160251A1 (fr) * 2014-04-15 2015-10-22 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Nouveaux composés luttant contre clostridium
CA3159526A1 (fr) * 2019-11-27 2021-06-03 Michael David Irwin Accepteurs non-fullerenes (nfas) utilises en tant que couches interfaciales dans des dispositifs semi-conducteurs de type perovskite
CN115073457B (zh) * 2022-08-09 2024-02-13 中国科学院长春应用化学研究所 一种萘双亚胺衍生物及其制备方法、应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3544303A (en) * 1968-04-03 1970-12-01 Stanford Research Inst Aromatic carboximides as herbicides
DE2951349A1 (de) * 1979-12-20 1981-07-02 Bayer Ag, 5090 Leverkusen Naphthalintetracarbonsaeurediimide als elektrische halbleiter und photoleiter
US4814366A (en) * 1986-10-07 1989-03-21 Mitsubishi Chemical Industries Limited Thermoplastic polyester resin composition
JPH02252585A (ja) * 1989-03-28 1990-10-11 Mitsubishi Kasei Corp 画像の保護方法
JPH02255789A (ja) * 1989-03-29 1990-10-16 Asahi Chem Ind Co Ltd 有機電場発光素子
CA2174582A1 (fr) * 1995-05-05 1996-11-06 Alexander Chucholowski Esters d'acide sulfurique et de sucres amines
EP0769532B1 (fr) * 1995-10-12 2002-03-13 Ciba SC Holding AG Colorants fluorescents de naphtolactamimide
JP2000113504A (ja) * 1998-10-05 2000-04-21 Mitsui Chemicals Inc 光記録媒体
JP3369515B2 (ja) * 1999-07-28 2003-01-20 京セラミタ株式会社 フタロシアニン結晶及びその製造方法と、これを含有した電子写真感光体
WO2002040479A1 (fr) * 2000-11-14 2002-05-23 Shionogi & Co., Ltd. Agents de traitement des infections a helicobacter

Also Published As

Publication number Publication date
WO2003095453A1 (fr) 2003-11-20
AU2003235908A1 (en) 2003-11-11

Similar Documents

Publication Publication Date Title
US20170320875A1 (en) Heterocyclic compounds as immunomodulators
EA020885B1 (ru) Ингибиторы протеинкиназы и их применение
CA3148196A1 (fr) Inhibiteurs de bromodomaine
TW200404804A (en) Pyrazolo[1,5-a]pyrimidine derivative and NAD(P)H oxidase inhibitor containing the same
US9708332B2 (en) Respiratory syncytial virus inhibitors
US11492352B2 (en) Arenavirus growth inhibitor comprising polycyclic carbamoylpyridone derivative
US9540356B2 (en) Compounds having a protective activity against toxins with intracellular activity
US11046682B2 (en) Fused heterocyclic derivatives, their preparation methods thereof and medical uses thereof
US10781179B2 (en) (−)-huperzine A processes and related compositions and methods of treatment
US20200247812A1 (en) Heterocyclic compounds and methods of use
WO2015066371A1 (fr) Composés spiro-oxadiazoline en tant qu'agonistes des récepteurs de l'acétylcholine α-7 nicotinique
AU2019220404B2 (en) Pyrimidine derivatives for prevention and treatment of bacterial infections
AU2018326721A1 (en) Compounds and compositions for IRE1 inhibition
JP2003313103A (ja) ４−アシルアミノピラゾール誘導体を有効成分として含有する農薬
TW200407323A (en) Compounds against helicobacter activity
AU2013221286B2 (en) Diaminopyrimidines useful as inhibitors of the human respiratory syncytial virus (RSV)
CA3127786A1 (fr) Modulateurs de gpr35
WO2020139803A1 (fr) Dérivés de benzothiadiazine et compositions les comprenant pour traiter des troubles médiés par l'adénosine
CA3230941A1 (fr) Agonistes d'ahr
EP3548034A1 (fr) Inhibiteurs à large spectre de filovirus
CA3090439A1 (fr) Compose presentant une activite inhibitrice de bet, son procede de preparation et son utilisation
CN103814025A (zh) 可用作胆碱激酶抑制剂的化合物
TW201103942A (en) Thia-triaza-cyclopentazulenes
JP2002138082A (ja) ４−アシルアミノピラゾール誘導体
JP2004529970A (ja) 新規のベンジルアミノピリミジン